Background Urinary Tract An infection (UTI) is among the most typical infections encountered in medical follow. Proof helps that empirical therapy tips based mostly on native bacterial spectrum and antimicrobial resistance (AMR) surveillance present the perfect medical outcomes and in addition stop the emergence of resistant strains. Antimicrobial resistance has been growing at an alarming charge all through the world. This warrants steady reporting and surveillance of the emergence of AMR among the many uropathogens throughout areas and nations. Supplies and strategies A retrospective cross-sectional examine utilizing antibiograms of grownup sufferers with culture-proven UTI throughout January 2011 and January 2017 was executed.
Comparative evaluation was carried out between the 2 examine durations for the prevalence, altering tendencies of antimicrobial resistance, and utilization of antimicrobials for testing. Outcomes The most typical organism cultured throughout every examine interval was Escherichia coli (56.6% and 51.6%). Essentially the most ceaselessly examined antibiotics have been ampicillin (97%, 88%), amikacin (85%, 85%), nitrofurantoin (95%, 95%), cephalexin (84%, 93%), and norfloxacin (83%, 83%). There was a major improve in resistance proportion famous for imipenem (by 29.8%), meropenem (by 18.3%), ertapenem (by 24.9%), ciprofloxacin (by 26.5%), nitrofurantoin (by 11.2%), amikacin (by 8.7%), and cefotaxime (by 7.4%) in 2017 as in comparison with 2011.
A major improve in susceptibility was seen for tobramycin (by 32.5%), cefepime (by 14.4%), and polymyxin (by 12.6%) in 2017 when in comparison with 2011. Conclusion Our evaluation has proven that there’s an alarmingly growing development for AMR amongst uropathogens on this area as in comparison with developed nations. Knowledge on altering tendencies of antimicrobial testing and reporting would possibly assist in strengthening antimicrobial surveillance.
The Barley HvWRKY6 Transcription Issue Is Required for Resistance In opposition to Pyrenophora teres f. teres
Barley is a crucial cereal crop worldwide due to its use within the brewing and distilling trade. Nonetheless, ample provides of high quality malting barley are threatened by international local weather change because of drought in some areas and extra precipitation in others, which facilitates epidemics brought on by fungal pathogens. The illness web type web blotch brought on by the necrotrophic fungal pathogen Pyrenophora teres f. teres (Ptt) has emerged as a worldwide risk to barley manufacturing and numerous populations of Ptt have proven a capability to beat deployed genetic resistances. The barley line CI5791 displays remarkably efficient resistance to numerous Ptt isolates from all over the world that maps to 2 main QTL on chromosomes 3H and 6H.
To determine genes concerned on this efficient resistance, CI5791 seed have been γ-irradiated and two mutants, designated CI5791-γ3 and CI5791-γ8, with compromised Ptt resistance have been recognized from an M2 inhabitants. Phenotyping of CI5791-γ3 and -γ8 × Heartland F2 populations confirmed three resistant to at least one inclined segregation ratios and CI5791-γ3 × -γ8 F1 people have been inclined, thus these unbiased mutants are in a single allelic gene. Thirty-four homozygous mutant (inclined) CI5791-γ3 × Heartland F2 people, representing 68 recombinant gametes, have been genotyped through PCR genotype by sequencing.
The information have been used for single marker regression mapping putting the mutation on chromosome 3H inside an approximate 75 cM interval encompassing the 3H CI5791 resistance QTL. Sequencing of the mutants and wild-type (WT) CI5791 genomic DNA following exome seize recognized unbiased mutations of the HvWRKY6 transcription issue positioned on chromosome 3H at ∼50.7 cM, throughout the genetically delimited area. Put up transcriptional gene silencing of HvWRKY6 in barley line CI5791 resulted in Ptt susceptibility, confirming that it features in NFNB resistance, validating it because the gene underlying the mutant phenotypes.

Allele evaluation and transcript regulation of HvWRKY6 from resistant and inclined strains revealed sequence id and upregulation upon pathogen problem in all genotypes analyzed, suggesting a conserved transcription issue is concerned within the protection towards the necrotrophic pathogen. We hypothesize that HvWRKY6 features as a conserved signaling part of protection mechanisms that restricts Ptt development in barley.
Metagenomics-Based mostly Strategy to Supply-Attribution of Antimicrobial Resistance Determinants – Identification of Reservoir Resistome Signatures
Metagenomics can unveil the genetic content material of the overall microbiota in several environments, similar to meals merchandise and the heart of people and livestock. It’s subsequently thought-about of nice potential to analyze the transmission of foodborne hazards as a part of source-attribution research. Supply-attribution of antimicrobial resistance (AMR) has historically relied on pathogen isolation, whereas metagenomics permits investigating the total span of AMR determinants.
On this examine, we hypothesized that the relative abundance of fecal resistome elements might be related to particular reservoirs, and that resistomes can be utilized for AMR source-attribution. We used shotgun-sequences from fecal samples of pigs, broilers, turkeys- and veal calves collected throughout Europe, and fecal samples from people occupationally uncovered to livestock in a single nation (pig slaughterhouse employees, pig and broiler farmers). We utilized each hierarchical and flat types of the supervised classification ensemble algorithm Random Forests to categorise resistomes into corresponding reservoir courses.
We recognized country-specific and -independent AMR determinants, and assessed the impression of country-specific determinants when attributing AMR resistance in people. Moreover, we carried out a similarity proportion evaluation with the total spectrum of AMR determinants to determine resistome signatures for the totally different reservoirs. We confirmed that the variety of AMR determinants essential to attribute a resistome into the proper reservoir will increase with a bigger reservoir heterogeneity, and that the impression of country-specific resistome signatures on prediction varies between nations. We predicted the next occupational publicity to AMR determinants amongst employees uncovered to pigs than amongst these uncovered to broilers. Moreover, outcomes advised that AMR publicity on pig farms was larger than in pig slaughterhouses.
Human resistomes have been extra just like pig and veal calves’ resistomes than to these of broilers and turkeys, and the vast majority of these resistome dissimilarities might be defined by a small set of AMR determinants. We recognized resistome signatures for every particular person reservoir, which embrace AMR determinants considerably related to on-farm antimicrobial use.
MX1 antibody |
|
22613 |
SAB |
100ul |
EUR 479 |
MX1 antibody |
|
22613-100ul |
SAB |
100ul |
EUR 468 |
MX1 antibody |
|
22124 |
SAB |
100ul |
EUR 479 |
MX1 antibody |
|
22124-100ul |
SAB |
100ul |
EUR 468 |
MX1 Antibody |
|
1-CSB-PA015249GA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20℃, Avoid freeze / thaw cycles. Antigen Affinity Purified
|
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
MX1 Antibody |
|
1-CSB-PA015249LA01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified |
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF, IP; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200, IP:1:200-1:2000 |
MX1 Antibody |
|
1-CSB-PA616832 |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
|
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:1000-1:2000, WB:1:200-1:1000 |
MX1 Antibody |
|
C44856-100ul |
Assay Biotech |
100μl |
EUR 217 |
|
Description: MX1 Rabbit Polyclonal Antibody |
MX1 Antibody |
|
C44856-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
|
Description: MX1 Rabbit Polyclonal Antibody |
MX1 Antibody |
|
E036545 |
EnoGene |
100μg/100μl |
EUR 255 |
|
Description: Available in various conjugation types. |
MX1 Antibody |
|
E307586 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
MX1 Antibody |
|
E301823 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
MX1 Antibody |
|
E91780 |
EnoGene |
100ul |
EUR 255 |
|
Description: Available in various conjugation types. |
MX1 Antibody |
|
E45R10939G-1 |
EnoGene |
100 ul |
EUR 395 |
MX1 Antibody |
|
E45R10939G-4 |
EnoGene |
50 ul |
EUR 295 |
MX1 Antibody |
|
MBS5312304-01mL |
MyBiosource |
0.1mL |
EUR 1065 |
MX1 Antibody |
|
MBS5312304-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4640 |
MX1 Antibody |
|
MBS5312339-01mL |
MyBiosource |
0.1mL |
EUR 1070 |
MX1 Antibody |
|
MBS5312339-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4655 |
MX1 Antibody |
|
MBS7048712-005mg |
MyBiosource |
0.05mg |
EUR 190 |
MX1 Antibody |
|
MBS7048712-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
MX1 Antibody |
|
MBS7125798-005mL |
MyBiosource |
0.05mL |
EUR 190 |
MX1 Antibody |
|
MBS7125798-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1205 |
MX1 Antibody |
|
MBS9607268-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
MX1 Antibody |
|
MBS9200058-008mL |
MyBiosource |
0.08mL |
EUR 210 |
MX1 Antibody |
|
MBS9200058-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
MX1 antibody |
|
MBS9401358-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1740 |
MX1 antibody |
|
MBS9405554-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1740 |
MX1 antibody |
|
MBS9410857-005mL |
MyBiosource |
0.05mL |
EUR 300 |
MX1 antibody |
|
MBS9410857-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1610 |
MX1 Antibody |
|
MBS9413771-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1230 |
MX1 antibody |
|
MBS834739-5x01mL |
MyBiosource |
5x0.1mL |
EUR 5090 |
MX1 Antibody |
|
MBS8500163-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
MX1 Antibody |
|
MBS8500163-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
MX1 Antibody |
|
MBS8500163-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
MX1 Antibody |
|
MBS8500163-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
anti- MX1 antibody |
|
FNab09996 |
FN Test |
100µg |
EUR 658.5 |
- Recommended dilution: WB: 1:500-1:2000
- IHC: 1:20-1:200
- Immunogen: Myxovirus resistance protein 1
- Uniprot ID: P20591
- Gene ID: 4599
- Research Area: Immunology, Signal Transduction
|
|
Description: Antibody raised against MX1 |
anti- MX1 antibody |
|
FNab05450 |
FN Test |
100µg |
EUR 658.5 |
- Recommended dilution: WB: 1:500-1:1000
- IP: 1:500-1:1000
- IHC: 1:20-1:200
- IF: 1:20-1:200
- Immunogen: Myxovirus resistance protein 1
- Uniprot ID: P20591
- Gene ID: 4599
- Research Area: Immunology, Signal Transduction
|
|
Description: Antibody raised against MX1 |
MX1 Antibody (Center) |
|
MBS9201668-008mL |
MyBiosource |
0.08mL |
EUR 210 |
MX1 Antibody (Center) |
|
MBS9201668-04mL |
MyBiosource |
0.4mL |
EUR 430 |
MX1 Antibody (Center) |
|
MBS9201668-5x04mL |
MyBiosource |
5x0.4mL |
EUR 1910 |
MX1 Antibody (Ascites) |
|
E45R11143G-1 |
EnoGene |
100 ul |
EUR 395 |
MX1 Antibody (Ascites) |
|
E45R11143G-4 |
EnoGene |
50 ul |
EUR 295 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx001476-100l |
Abbexa |
100 µl |
EUR 400 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx001476-20l |
Abbexa |
20 µl |
EUR 175 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx001476-50l |
Abbexa |
50 µl |
EUR 275 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx048492-100g |
Abbexa |
100 µg |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx048492-200g |
Abbexa |
200 µg |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx048492-50g |
Abbexa |
50 µg |
EUR 337.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx025431-400l |
Abbexa |
400 µl |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx025431-80l |
Abbexa |
80 µl |
EUR 518.75 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx025432-400l |
Abbexa |
400 µl |
EUR 525 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx025432-80l |
Abbexa |
80 µl |
EUR 281.25 |
- Shipped within 5-10 working days.
|
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102172-100l |
Abbexa |
100 µl |
EUR 287.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102172-1ml |
Abbexa |
1 ml |
EUR 825 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102172-200l |
Abbexa |
200 µl |
EUR 362.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102173-100l |
Abbexa |
100 µl |
EUR 287.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102173-1ml |
Abbexa |
1 ml |
EUR 850 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102173-200l |
Abbexa |
200 µl |
EUR 375 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102174-100l |
Abbexa |
100 µl |
EUR 300 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102174-1ml |
Abbexa |
1 ml |
EUR 875 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102174-200l |
Abbexa |
200 µl |
EUR 375 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102175-100l |
Abbexa |
100 µl |
EUR 300 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102175-1ml |
Abbexa |
1 ml |
EUR 900 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx102175-200l |
Abbexa |
200 µl |
EUR 387.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx113971-100l |
Abbexa |
100 µl |
EUR 612.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx339617-100l |
Abbexa |
100 µl |
EUR 350 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx339617-50l |
Abbexa |
50 µl |
EUR 250 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx145262-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx145262-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx145262-96tests |
Abbexa |
96 tests |
EUR 337.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx130316-100l |
Abbexa |
100 µl |
EUR 300 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx130316-1ml |
Abbexa |
1 ml |
EUR 900 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx130316-200l |
Abbexa |
200 µl |
EUR 387.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx216986-100tests |
Abbexa |
100 tests |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx216986-200tests |
Abbexa |
200 tests |
Ask for price |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx216986-20tests |
Abbexa |
20 tests |
EUR 350 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx235450-100g |
Abbexa |
100 µg |
EUR 350 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx317903-100g |
Abbexa |
100 µg |
EUR 362.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx317903-20g |
Abbexa |
20 µg |
EUR 162.5 |
Interferon-Induced GTP-Binding Protein Mx1 (MX1) Antibody |
|
abx317903-50g |
Abbexa |
50 µg |
EUR 250 |
Polyclonal MX1 + MX2 antibody |
|
APG02927G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MX1 + MX2 . This antibody is tested and proven to work in the following applications: |
MX1 Antibody, HRP conjugated |
|
1-CSB-PA015249LB01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified |
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
MX1 Antibody, HRP conjugated |
|
MBS7048713-005mg |
MyBiosource |
0.05mg |
EUR 190 |
MX1 Antibody, HRP conjugated |
|
MBS7048713-01mg |
MyBiosource |
0.1mg |
EUR 270 |
MX1 Antibody, HRP conjugated |
|
MBS7048713-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
MX1 Antibody, FITC conjugated |
|
1-CSB-PA015249LC01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified |
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
MX1 Antibody, FITC conjugated |
|
MBS7048714-005mg |
MyBiosource |
0.05mg |
EUR 190 |
MX1 Antibody, FITC conjugated |
|
MBS7048714-01mg |
MyBiosource |
0.1mg |
EUR 270 |
MX1 Antibody, FITC conjugated |
|
MBS7048714-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
MX1 Antibody, Biotin conjugated |
|
1-CSB-PA015249LD01HU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
- Form: Liquid
- Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 >95%, Protein G purified |
|
Description: A polyclonal antibody against MX1. Recognizes MX1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
MX1 Antibody, Biotin conjugated |
|
MBS7048715-005mg |
MyBiosource |
0.05mg |
EUR 190 |
MX1 Antibody, Biotin conjugated |
|
MBS7048715-01mg |
MyBiosource |
0.1mg |
EUR 270 |
MX1 Antibody, Biotin conjugated |
|
MBS7048715-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
MX1 Antibody (Rabbit Polyclonal) |
|
MBS8508266-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 565 |
MX1 Antibody (Rabbit Polyclonal) |
|
MBS8508266-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 565 |
MX1 Antibody (Rabbit Polyclonal) |
|
MBS8508266-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 565 |
MX1 Antibody (Rabbit Polyclonal) |
|
MBS8508266-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 565 |
MX1 Antibody (Rabbit Polyclonal) |
|
MBS8508266-02mL |
MyBiosource |
0.2mL |
EUR 345 |
MX1 Polyclonal Antibody |
|
ABP59348-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
- Immunogen information: Synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580
- Applications tips:
|
|
Description: A polyclonal antibody for detection of MX1 from Human, Rat. This MX1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580 |
MX1 Polyclonal Antibody |
|
ABP59348-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
- Immunogen information: Synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580
- Applications tips:
|
|
Description: A polyclonal antibody for detection of MX1 from Human, Rat. This MX1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580 |
MX1 Polyclonal Antibody |
|
ABP59348-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
- Immunogen information: Synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580
- Applications tips:
|
|
Description: A polyclonal antibody for detection of MX1 from Human, Rat. This MX1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human MX1 protein at amino acid sequence of 500-580 |
MX1 Conjugated Antibody |
|
C36545 |
SAB |
100ul |
EUR 476.4 |
MX1 Conjugated Antibody |
|
C38296 |
SAB |
100ul |
EUR 476.4 |
MX1 Polyclonal Antibody |
|
BT-AP11593-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
|
|
Description: This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. |
MX1 Polyclonal Antibody |
|
BT-AP11593-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
|
|
Description: This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. |
MX1 Polyclonal Antibody |
|
BT-AP11593-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
|
|
Description: This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. |
MX1 Polyclonal Antibody |
|
MBS128154-002mL |
MyBiosource |
0.02mL |
EUR 200 |
MX1 Polyclonal Antibody |
|
MBS128154-005mL |
MyBiosource |
0.05mL |
EUR 255 |
We attributed human resistomes to totally different livestock reservoirs utilizing Random Forests, which allowed figuring out pigs as a possible supply of AMR in people. This examine thus demonstrates that it’s doable to use metagenomics in AMR source-attribution.